Cardiac Pacemaker Evaluation Services — NCD 160 | CMS Coverage Update

TL;DR: The Centers for Medicare & Medicaid Services modified NCD 160, its cardiac pacemaker evaluation coverage policy, effective March 7, 2026. Here's what changes for billing teams.

CMS updated NCD 160 governing post-implant follow-up and evaluation of cardiac pacemakers under Medicare. The policy does not list specific CPT or HCPCS codes, but it directly shapes how Medicare Administrative Contractors process pacemaker monitoring claims — and the monitoring frequency guidelines carry real claim denial risk if your documentation doesn't hold up.

Quick-Reference Table

CMS Cardiac Pacemaker Coverage Criteria and Medical Necessity Requirements 2026

NCD 160 is the National Coverage Determination governing Medicare coverage of post-implant cardiac pacemaker evaluation services. The updated coverage policy applies to lithium battery-powered pacemakers only. Mercury-zinc battery-powered units are no longer manufactured and have been almost entirely replaced. If your MAC still receives claims for mercury-zinc units, the 1980 guidelines still apply to those — but that's a shrinking universe.

The CMS cardiac pacemaker coverage policy covers two pacemaker types: single-chamber and dual-chamber. Single-chamber pacemakers sense and pace the ventricles. Dual-chamber pacemakers sense and pace both the atria and ventricles. That distinction matters because each type has different monitoring frequency guidelines, and your billing team needs to apply the right framework to each.

Here's where billing teams get tripped up: a dual-chamber unit programmed to pace only the ventricles must be treated as a single-chamber unit for billing purposes. That's true whether the reprogramming happened at implant or later. If you're billing monitoring for a dual-chamber device but the physician reprogrammed it for ventricular pacing only, you're billing in single-chamber territory. Get the device programming documentation in the chart before you bill.

Medical necessity under this coverage policy sits with the treating physician. The physician decides how often a pacemaker should be monitored. That judgment can — and should — shift over time as the patient's condition changes. Your documentation needs to reflect that. A static monitoring schedule with no clinical justification for frequency is a claim denial waiting to happen.

When monitoring is performed by a third party — a commercial monitoring service or hospital outpatient department — the physician's prescription is required. That prescription must be renewed at least annually. If your organization provides monitoring services and you're not tracking prescription renewal dates, you're billing without a safety net. One lapsed prescription can trigger recoupment across an entire monitoring episode.

Prior authorization isn't explicitly addressed in this version of the policy, but that doesn't mean your MAC won't require documentation review. Because MACs develop their own local frequency guidelines under this NCD, prior authorization requirements can vary by region. Check your MAC's local coverage determination for pacemaker monitoring before assuming you're clear.

CMS Cardiac Pacemaker Monitoring Exclusions and Non-Covered Indications

NCD 160 doesn't contain an explicit "not covered" list. But the coverage policy creates real coverage boundaries through its frequency guidelines. Monitoring performed at frequencies that fall outside what the physician prescribed — or outside MAC guidelines — won't be reimbursed.

Monitoring claims submitted without a valid, current physician prescription are not covered when a third party performs the monitoring. There's no gray area here. No prescription, no coverage. Expired prescription, no coverage.

The policy also signals that dual-chamber units reprogrammed for single-chamber function must be billed as single-chamber. Billing a dual-chamber monitoring rate for a single-chamber-programmed device is miscoding, full stop. That creates both claim denial exposure and compliance risk.

Coverage Indications at a Glance

CMS Cardiac Pacemaker Billing Guidelines and Action Items 2026

The effective date of March 7, 2026 means these guidelines are already in force. If your team hasn't reviewed your pacemaker monitoring billing workflows against NCD 160, do it now.

The real issue with NCD 160 is that it delegates significant discretion to individual physicians and individual MACs. That's not a problem if your documentation is clean. It becomes a serious problem if your billing team is operating on assumptions about what's covered without verified prescription and frequency documentation. Cardiac pacemaker billing is not high-complexity on its face — but the paper trail requirements are exacting.

CPT, HCPCS, and ICD-10 Codes for Cardiac Pacemaker Evaluation Under NCD 160

The policy data provided for NCD 160 does not list specific CPT, HCPCS, or ICD-10 codes. This is consistent with how some NCDs are structured — they define coverage criteria and leave code-level specifics to MAC-level billing guidelines and local coverage determinations.

For cardiac pacemaker evaluation billing, your team should consult:

• Your MAC's LCD for the specific CPT and HCPCS codes recognized for pacemaker monitoring in your region
• CMS Claims Processing Instructions cross-referenced in NCD 160 for procedural billing guidance
• Your billing guidelines documentation for the codes your organization currently uses for single-chamber and dual-chamber evaluation services

Do not assume that codes used historically are still valid without checking the current MAC LCD. MACs update code lists independently of the NCD, and a code that processed cleanly last year may now require additional documentation or carry a new frequency limitation.

If you're unsure which codes your MAC recognizes for pacemaker monitoring — transtelephonic versus in-clinic, single-chamber versus dual-chamber — contact your MAC directly or loop in your billing consultant before the next claim cycle. This is one of those areas where a 15-minute call saves a batch of denials.